Generate Biomedicines(GENB)
Focus: Generate Biomedicines is a publicly traded biotech company leveraging machine learning to design novel therapeutic proteins, with a focus on respiratory and immunology indications. The company operates at mid-cap scale (~51-200 employees) from Somerville, MA.
Profile data last refreshed 10h ago · AI intelligence enriched 1mo ago
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
13+1 this month
Stable — net +1 jobs in 30d
10 added, 9 removed. Backfill posture.
Should You Work at Generate Biomedicines?
AI assessmentBest suited for research scientists, machine-learning engineers, and early-stage clinical developers willing to bet on a cutting-edge platform technology; offers upside if GB-0895 succeeds, but carries execution risk typical of pre-commercialization biotechs.
Why Work Here
- Early-stage pipeline with Phase 3 lead candidate (GB-0895 in severe asthma) offers visibility into a potential near-term regulatory catalyst and proof-of-concept validation for the ML protein-design platform.
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
GB-0669
SARS CoV-2Clinical Trials (1)
NCT07050511Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-0669 in Healthy Adult Participants
Phase 1Help build intelligence for Generate Biomedicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.